These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
197 related items for PubMed ID: 8232632
1. ESRD program at the crossroads of health care reform. Neumann ME. Nephrol News Issues; 1993 Oct; 7(10):5, 40. PubMed ID: 8232632 [No Abstract] [Full Text] [Related]
2. Can we revitalize the ESRD program? McFeeley T. Nephrol News Issues; 2004 Apr; 18(5):42-3, 47, 87. PubMed ID: 15125164 [No Abstract] [Full Text] [Related]
4. The ESRD bundle creates a perfect storm. Crafton D. Nephrol News Issues; 2010 Jul; 24(8):36, 38. PubMed ID: 20695321 [No Abstract] [Full Text] [Related]
5. ESRD data system needs a fix. Lack of updates impacts beneficiaries, costs Medicare; USRDS looks elsewhere for accurate data. Nephrol News Issues; 2002 Apr; 16(5):8, 10. PubMed ID: 11962159 [No Abstract] [Full Text] [Related]
6. The direction of end-stage renal disease reimbursement in the United States. Lockridge RS. Semin Dial; 2004 Apr; 17(2):125-30. PubMed ID: 15043614 [Abstract] [Full Text] [Related]
7. A quarter century of medicare expenditures for ESRD. Eggers PW. Semin Nephrol; 2000 Nov; 20(6):516-22. PubMed ID: 11111852 [Abstract] [Full Text] [Related]
9. Medicare and erythropoietin. Steinbrook R. N Engl J Med; 2007 Jan 04; 356(1):4-6. PubMed ID: 17202449 [No Abstract] [Full Text] [Related]
10. Medicare's ESRD Program, Part 1: Dialysis. Long HW. Physician Exec; 1989 Jan 04; 15(2):24-6. PubMed ID: 10313034 [Abstract] [Full Text] [Related]
11. In a bundling era, finding a fair price for ESRD services. Sullivan JD. Nephrol News Issues; 2007 Mar 04; 21(4):37, 39-40. PubMed ID: 17393926 [No Abstract] [Full Text] [Related]
12. The organization of medical care. Lessons from the Medicare end stage renal disease program. Levinsky NG. N Engl J Med; 1993 Nov 04; 329(19):1395-9. PubMed ID: 8413437 [No Abstract] [Full Text] [Related]
13. Extension of Medicare immunosuppressive drug benefits: a "no brainer" that did not happen. Bennett WM. Clin J Am Soc Nephrol; 2010 May 04; 5(5):743. PubMed ID: 20448072 [No Abstract] [Full Text] [Related]
14. The 2011 ESRD prospective payment system: perspectives from Fresenius Medical Care, a large dialysis organization. Lacson E, Hakim RM. Am J Kidney Dis; 2011 Apr 04; 57(4):547-9. PubMed ID: 21333423 [No Abstract] [Full Text] [Related]
15. The 2011 ESRD prospective payment system: welcome to the bundle. Weiner DE. Am J Kidney Dis; 2011 Apr 04; 57(4):539-41. PubMed ID: 21333431 [No Abstract] [Full Text] [Related]
16. The 2011 ESRD prospective payment system: an uncontrolled experiment. Winkelmayer WC, Chertow GM. Am J Kidney Dis; 2011 Apr 04; 57(4):542-6. PubMed ID: 21333428 [No Abstract] [Full Text] [Related]
17. The American health care system. The End Stage Renal Disease Program. Iglehart JK. N Engl J Med; 1993 Feb 04; 328(5):366-71. PubMed ID: 8419833 [No Abstract] [Full Text] [Related]